Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6 Pt 2
pubmed:dateCreated
1996-10-2
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1053-2498
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
S227-34
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8719491-Adult, pubmed-meshheading:8719491-Aged, pubmed-meshheading:8719491-Coronary Artery Disease, pubmed-meshheading:8719491-Cyclosporine, pubmed-meshheading:8719491-Dose-Response Relationship, Drug, pubmed-meshheading:8719491-Female, pubmed-meshheading:8719491-Follow-Up Studies, pubmed-meshheading:8719491-Graft Rejection, pubmed-meshheading:8719491-Heart Transplantation, pubmed-meshheading:8719491-Humans, pubmed-meshheading:8719491-Immunosuppressive Agents, pubmed-meshheading:8719491-Male, pubmed-meshheading:8719491-Middle Aged, pubmed-meshheading:8719491-Postoperative Complications, pubmed-meshheading:8719491-Retrospective Studies, pubmed-meshheading:8719491-Risk Factors, pubmed-meshheading:8719491-Tunica Intima, pubmed-meshheading:8719491-Ultrasonography, Interventional
pubmed:articleTitle
The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. Sandoz/CVIS Investigators.
pubmed:affiliation
St. Louis University Health Sciences Center, MO 63110, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study